Ejaculatio praecox — ein Update

Giuliano F, Hellstrom WJ. The pharmacological treatment of premature ejaculation. BJU Int 2008;102:668–675

Abdel-Hamid IA. Pharmacologic treatment of rapid ejaculation: levels of evidencebased review. Curr Clin Pharmacol 2006;:243–254

Salonia A, Saccà A, Briganti A, Del Carro U, Dehò F, Zanni G, Rocchini L, Rabaer M, Guazzoni G, Riggatti P, Montorsi F. Quantative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: A case-controlled study. J Sex Med 2009;6:1755–1762

Rowland DL. Psychophysiology of ejaculatory function and dysfunction. World J Urol 2008;23:82–88.

Rowland D, McMahon CG, Abdo C et al. Disorders of Orgasm and Ejaculation in Men. J Sex Med 2010;7:1668–1686m_1782 1668

Waldinger MD. Premature ejaculation: different pathophysiologies and etiologies determine its treatment. J Sex Marital Ther. 2008;34(1):1–13.

Köhn, F. M. Wenn Männer zu früh kommen. MMW-fortschr Med 2003; 46: 912–916

Porst, H., Montorsi, F., Rosen et al. The Premature Ejaculation Prevalence and Attitudes (PEPA) Survey: Prevalence, Comorbidities, and Professional Help-Seeking. Eur. Urol 2007;51, 816–824

Kreutzer N, Sommer F, Klotz T, Engelmann U. Aktuel Urol 2001;32:435–438

The Alza Corporation: 2002. Multi country concept evaluation and assessment of PE incidence study. Ref Type: Data File

Mathers, M J; Schmitges, J; Klotz, T; Sommer, F. Introduction Into the Diagnostics and Treatment of Premature Ejaculation. Dtsch Arztebl 2007;104(50): A-3475

Althof S E, Abdo C H, Dean J et al. International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010; 7: 2947–2969

Laumann EO, Nicolosi A, Glasser DB et al: Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17 (1): 39–57

Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007 Mar;51(3):816–823

Waldinger MD, McIntosh J, Schweitzer DH. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J Sex Med. 2009; 6(10):2888–2889

Jannini EA, Lenzi A. Epidemiology of premature ejaculation Curr Opin Urol. 2005;15(6):399–403

Abdel-Hamid IA.. Pharmacologic treatment of rapid ejaculation: levels of evidencebased review. Curr Clin Pharmacol1 2006;243–254

Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005 2(4):492–497

Schapiro B. Premature ejaculation. A review of 1130 cases. J Urol 1943;50:374–379

Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res. 1998; 92(2):111–118.

Jern P, Santtila P, Witting K, Alanko K, Harlaar N, Johansson A, von der Pahlen B, Varjonen M, Vikström N, Algars M, Sandnabba K. Premature and delayed ejaculation: genetic and environmental effects in a population-based sample of finish twins..J Sex Med. 2007; 4(6):1739–1749.

Janssen PK, Bakker SC, Réthelyi J. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med. 2009 Jan;6(1):276–284

Semans JH. Premature ejaculation: A new approch. S Afr Med J 1956; 49:353–358.

Masters WH, Johnson VE. Huiman sexual inadequacy. Boston, MA: Little Brown; 1970

McMahon CG. Clinical trail methodology in premature ejaculation observational, interventional, and treatment preference studies — part 1 — defining and selecting the study population J Sex Med. 2008;5(8):1805–1816

Rosen RC, McMahon CG, Niederberger C, Broderick GA, Jamieson C, Gagnon DD. Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol. 2007;177(3):1059–1064

Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practise. BJU Int. 2009;103(3):358–364

Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med. 2006;3(3):465–475

Sommer F, Korda B, Mathers MJ, Klotz T. Ejaculatio praecox. 1 Auflage — Bremen: UNI MED, 2010.

Waldinger MD. Lifelong premature ejaculation: from authority-based to evidence-based medicine. BJU Int 2004;93:201–207

Van den Broucke H, Everaert K, Peersman W et al. Ejaculation latency times and their relationship to penile sensitivity in men with normal sexual function. J Urol. 2007 Jan;177(1):237–240.

Mathers MJ, Sommer F, Degener S, Brandt AS, Roth S. Premature ejaculation in urological routine practice. Aktuelle Urol. 2013 Jan;44(1):33–39.

Morales A, Barada J, Wyllie MG. A review of the current status of topical treatments for premature ejaculation. BJI Int 2007;100(3): 493–501

Hawton K, Catalan J, Faff J: Sex therapy for erectile dysfunction: characteristics of couples, treatment outcome, and prognostic factors. Arch Sex Behav 1992; 21:161–175

Sadeghi-Nejad H, Watson R. Premature ejaculation: current medical treqtment and new directions (CME). J Sex Med 2008;5(5):1037–1050

Waldinger MD. Premature ejaculation: definition and drug treatment. Drugs. 2007; 67(4):547–568

Mathers MJ, Klotz T, Roth S, Lümmen G, Sommer F. Safety and efficacy of Vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study. Andrologia.2009; 41(3):169–175

Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methological disegne for the interpretation of efficacy of drug treatment of prematureejaculation: a systematic review and meta-analyse. Int J Impot Res. 2004; 16(4):369–381

Tanrikut C, Feldman AS, Altemus M, Paduch DA, Schlegel PN. Adverse effect of paroxetine on sperm. Fertil Steril. 2010 Aug;94(3):1021–1026

Koyuncu H Serefoglu EC, Yencilek E, Atalay H, Akbas NB, Sarica K. Escitalopram treatment for premature ejaculation has a negative effect on semen parameters. Int J Impot Res. 2011 Nov-Dec;23(6):257–261.

Porst H, McMahon CG, Althof SE, Sharlip I, Bull S, Aquilina JW, Tesfaye F, Rivas DA. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 Dapoxetine trails. J Sex Med. 2010;7(6):2231–2242

McMahon CG, Althof SE, Kaufman JM, Buvat J, Levine SB, Aquilina JW, Tesfaye F, Rothman M, Rivas DA, Porst H. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. J Sex Med. 2011 Feb;8(2):524–539.

Sommer F, Klotz T, Mathers MJ. Treatment of premature ejaculation: A comparative vardenafil and SSRI crossover study. J Urol 2005; 173:202

Safarinejad MR, Hosseini SY. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol. 2006; 26(1):27–31

Cavallini G..Alpha-1 blockade pharmacotherapy in privative psychogenic premature ejaculation resistant to psychotherapy. Eur Urol. 1995;28(2):126–130.

Gabuev A, Oelke M. Latest Trends and Recommendations on Epidemiology, Diagnosis, and Treatment of Benign Prostatic Hyperplasia (BPH). Aktuel Urol 2011; 42: 167–178